BresMed was established in 2006, and now has over 170 employees in the UK, Ireland, India, the Netherlands, and the US. We are a health economic and outcomes research (HEOR) consultancy, committed to engaging in open collaboration with our healthcare clients. Our services support a wide range of clients including top pharmaceutical companies, medical device manufacturers and small biopharma at the Global, European and Affiliate level. We have a portfolio that covers the full product development pipeline from early planning to implementation and launch. Our services fall into three interrelated groups: Evidence Review, Evidence Development, and Communications, with a common thread of Strategy & Insight, to ensure projects meet our clients’ needs helping them to define, develop and execute successful HEOR strategies. BresMed employees have extensive experience of HTA submission and reimbursement (including NICE, SMC, AWMSG, NCPE, CADTH, PBAC, TLV) gained from backgrounds in industry, consulting and academia. We offer a breadth and depth of experience which is brought into play for our clients by blending our expert technical knowledge with strategic knowhow.